×
Metastatic renal cell carcinoma (RCC) is a tumor entity with poor prognosis due to limited therapy options. Tyrosine kinase inhibitors (TKI) represent the ...
People also ask
Jun 23, 2017 · Here, we discovered the novel LncRNA-SARCC, which was suppressed and associated with better prognosis in RCC. Preclinical studies using multiple ...
Purpose: DMS612 is a dimethane sulfonate analog with bifunctional alkylating activity and preferential cytotoxicity to human renal cell carcinoma (RCC) in ...
Metastatic papillary renal cell carcinoma (RCC) to the heart has never been reported. ... (RA)., However, right ventricular metastases ... 2003;27:612–24. doi: ...
Sep 19, 2023 · • Approve RCC Position on behalf of the RCC Board ... WG RA/WRC – develops RCC Position, RCC Common Proposals and ... WRC- 15), 422 (WRC-12), 612 ( ...
Purpose: DMS612 is a dimethane sulfonate analog with bifunctional alkylating activity and preferential cytotoxicity to human renal cell carcinoma (RCC) in the ...
Jan 1, 2011 · Metastatic RCC in distant organs.—Renal cell carcinoma, particularly the clear cell type, frequently metastasizes, sometime long before or after ...
Jan 11, 2024 · Abstract. Immune checkpoint inhibitors have significantly transformed the treatment paradigm for metastatic renal cell carcinoma (RCC), offering ...
OBJECTIVE. The objective of our study was to describe the T1 and T2 signal intensity characteristics of papillary renal cell carcinoma (RCC) and clear cell ...
Mar 11, 2019 · Clear cell renal cell carcinoma (CCRCC) is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm ...